How tumor-specific modulation frequencies were discovered

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In the spring of 2001, I visited a longtime friend and collaborator, Alexandre Barbault, to share with him my vision of using low levels radiofrequency electromagnetic fields for the treatment of cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings.
Boris C. Pasche
Charles L. Spurr Professor of Medicine, Chairman, Department of Cancer Biology; Director, Comprehensive Cancer Center of Wake Forest University

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login